BNR
NASDAQ
$10.07
Burning Rock Biotech Ltd (BNR)
Burning Rock Biotech Limited primarily develops and provides screening tests for cancer therapies in the People's Republic of China. The company is headquartered in Guangzhou, China.
Sector:
Healthcare
Industry:
Diagnostics & Research
Target: $4.03 (-59.98%)
Market Cap
$64M
Free Cash Flow Yield
-20.77%
Beta (5Y)
0.98
Price Chart
Valuation
Market Cap$64M
P/S0.52
P/B1.10
Profitability
Total Revenue (TTM)$71M
Gross Profit (TTM)$53M
EBITDA-$42M
Profit Margin-67.2%
Operating Margin-69.3%
EPS-$9.70
Financial Health
Free Cash Flow Yield-20.77%
Growth & Risk
Revenue 5Y CAGR+6.21%
FCF 5Y CAGR-18.46%
Beta (5Y)0.98
Sharpe Ratio1.20